Key result
Precision biotechnology and bioengineering innovations can enhance personalized obesity management via multi-omics and synthetic biology.
Why the study?
Conventional obesity interventions remain limited by poor durability, safety concerns, and scalability, underscoring the need for precision alternatives that target upstream regulatory nodes.
Design
Review
Authors
Loading...
May inform obesity research directions; leaves open clinical translation pending prospective validation.
Han et al. (2025) studied this question. Precision biotechnology and bioengineering innovations, such as multi-omics and synthetic biology, can significantly enhance personalized obesity management strategies.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: